SCHEMBL4374975

SCHEMBL4374975

CCOC(=O)c1csnc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 3/20 0.55
DBF4 Q9UBU7 3/20 0.55
MAPT P10636 4/20 0.53
KDM4E B2RXH2 3/20 0.53
TSHR P16473 2/20 0.51
NPC1 O15118 1/20 0.51
POLB P06746 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.45
CNR1 P21554 2/20 0.44
HPGD P15428 2/20 0.43
ALOX15 P16050 1/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 1/20 0.42
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
DPP9 Q86TI2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3436621 0.87 CDC7 (0.43) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL11389226 0.82 GCGR (0.50) MAPTKDM4ENPC1POLBRAB9A
SCHEMBL4369005 0.80 SMN1; SMN2 (0.50) CDC7DBF4KDM4ETSHRNPC1
SCHEMBL3436162 0.76 MAPT (0.57) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL24013843 0.76 TSHR (0.45) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL30242776 0.76 TSHR (0.45) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL30228245 0.76 TSHR (0.45) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL24013622 0.76 TSHR (0.45) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL1866115 0.75 MAPT (0.50) CDC7DBF4MAPTKDM4ETSHR
SCHEMBL4114757 0.75 MAPT (0.56) CDC7DBF4MAPTKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed